| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Orange At Orange, you can. Orange is one of the world’s leading telecommunications operators with sales of 43.5 billion euros in 2022 and 136,000 employees worldwide at 31 December 2022, including 75,000 employees in France. The Group has a total customer base of 287 million customers worldwide at 31 December 2022, including 242 million mobile customers and 24 million fixed broadband customers. The Group is present in 26 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023, the Group presented its strategic plan « Lead the … Tags: CAC40 Sectors: | 2864 | 2202 | 435 |
 | Fondation Adolphe de Rothschild Head and Neck Expertise. Created in 1905 in the 19th district of Paris, the Adolphe de Rothschild Foundation Hospital is a private health institution of collective interest (ESPIC) specialized in all pathologies of the head and neck for adults and children. This university hospital offers excellent care at a conventional rate (non-profit) and treats nearly 300,000 patients every year. Providing the continuum of care, research and training, the Rothschild Foundation Hospital pilots 125 clinical research studies each year, publishes nearly 300 scientific articles and trains nearly 700 students. The services of the Rothschild Foundation Hospital regularly appear at the top … Sectors: | 173 | 71 | 98 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: | 446 | 391 | 31 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 2052 | 1501 | 463 |
 | Région Ile de France The Paris Region is a major business and techno hub in Europe. Standing at the crossroads of European and worldwide trade, the Paris Region is France's leading economic region. It represents 31% of French GDP. Consisting of 8 départements and 1,280 municipalities, the Paris Region hosts the largest population of french Regions : 12.5 million inhabitants, that is younger than the national average. As Europe’s leading employment area, it boasts a highly qualified workforce : 33% of French executives. The Paris Region hosts 22% of France’s universities, 25% of its engineering schooland 20% of its business schools. Invest in Paris … Sectors: | 3123 | 2512 | 466 |
 | STATION F The biggest startup campus in the world. STATION F is the world's biggest startup campus based in Paris, gathering a whole entrepreneurial ecosystem under one roof. Startups Sectors: | 1373 | 1176 | 166 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 672 | 460 | 220 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 434 | 350 | 44 |
 | Alexion Pharmaceuticals, Inc. Rare inspiration. Changing lives. Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in … Sectors: | 172 | 121 | 18 |
Law Practice